Literature DB >> 15199382

Screening of the ARX gene in 682 retarded males.

Karen Grønskov1, Helle Hjalgrim, Inge-Merete Nielsen, Karen Brøndum-Nielsen.   

Abstract

The newly identified gene, ARX, when mutated has been shown to cause both syndromic and nonsyndromic forms of mental retardation. It seems that the less severe forms are due to polyalanine expansions and missense mutations in the gene. We screened 682 developmentally retarded males for polyalanine expansions in ARX in order to examine the contribution of ARX mutations to the causes of developmental retardation. We also reinvestigated 11 putative MRX and three MR families where no cause of mental retardation had been found, by mutational analysis of ARX. Mutational analysis was also performed in 11 probands with autism from families with two or more affected males. We find that previously described polyalanine expansions of ARX are not a common cause of mental retardation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199382     DOI: 10.1038/sj.ejhg.5201222

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Comparative frequency of fragile-X (FMR1) and creatine transporter (SLC6A8) mutations in X-linked mental retardation.

Authors:  J L Mandel
Journal:  Am J Hum Genet       Date:  2004-10       Impact factor: 11.025

Review 2.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

3.  Maternal mosaicism for mutations in the ARX gene in a family with X linked mental retardation.

Authors:  K Poirier; J Abriol; I Souville; C Laroche-Raynaud; C Beldjord; B Gilbert; J Chelly; T Bienvenu
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

4.  Screening of ARX in mental retardation families: Consequences for the strategy of molecular diagnosis.

Authors:  K Poirier; D Lacombe; B Gilbert-Dussardier; M Raynaud; V Desportes; A P M de Brouwer; C Moraine; J P Fryns; H H Ropers; C Beldjord; J Chelly; T Bienvenu
Journal:  Neurogenetics       Date:  2005-10-19       Impact factor: 2.660

5.  Mutation screening of the ARX gene in patients with autism.

Authors:  Pauline Chaste; Gudrun Nygren; Henrik Anckarsäter; Maria Råstam; Mary Coleman; Marion Leboyer; Christopher Gillberg; Catalina Betancur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-03-05       Impact factor: 3.568

6.  Immunodeficiency in a Patient with 22q11.2 Distal Deletion Syndrome and a p.Ala7dup Variant in the MAPK1 Gene.

Authors:  Ana I Sánchez; Mary A García-Acero; Angela Paredes; Rossi Quero; Rita I Ortega; Jorge A Rojas; Daniel Herrera; Miguel Parra; Karol Prieto; Juana Ángel; Luz-Stella Rodríguez; Juan C Prieto; Manuel Franco
Journal:  Mol Syndromol       Date:  2020-02-05

Review 7.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

Review 8.  Regulation of histone H3K4 methylation in brain development and disease.

Authors:  Erica Shen; Hennady Shulha; Zhiping Weng; Schahram Akbarian
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

9.  A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome).

Authors:  Mitsuhiro Kato; Shinji Saitoh; Atsushi Kamei; Hideaki Shiraishi; Yuki Ueda; Manami Akasaka; Jun Tohyama; Noriyuki Akasaka; Kiyoshi Hayasaka
Journal:  Am J Hum Genet       Date:  2007-06-11       Impact factor: 11.025

10.  Wwox deletion leads to reduced GABA-ergic inhibitory interneuron numbers and activation of microglia and astrocytes in mouse hippocampus.

Authors:  Tabish Hussain; Hyunsuk Kil; Bharathi Hattiangady; Jaeho Lee; Maheedhar Kodali; Bing Shuai; Sahithi Attaluri; Yoko Takata; Jianjun Shen; Martin C Abba; Ashok K Shetty; C Marcelo Aldaz
Journal:  Neurobiol Dis       Date:  2018-10-02       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.